Stine R. Meehan, PhD
- 3Articles
- 23.5KReads
- 2019–2023Active
- 12Collaborators
- 29Citations
About
Stine R. Meehan, PhD, affiliated with H. Lundbeck A/S in Valby, Denmark, has published research focused on metabolic changes and body weight in patients treated with brexpiprazole for major depressive disorder and schizophrenia. Meehan's work includes analyses of short- and long-term clinical studies examining brexpiprazole's effects on metabolic parameters and patient functioning. Collaborations have involved coauthors such as Catherine Weiss, John W. Newcomer, and Christoph U. Correll.
Publications
Brexpiprazole in Patients With MDD and Prediabetes
August 28, 2023
Brexpiprazole in MDD—Metabolic Parameters and Weight
October 1, 2019
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.